VA Secretary David Shulkin, MD told the House Committee on Veterans’ Affairs that the transition from VistA to Cerner will take seven to eight years, with the first go-live anticipated 18 months after contracts are signed.
Published in both Nature and Science, researchers from the Broad Institute of MIT and Harvard describe a new gene-editing technique that improves on CRISPR-Cas9. The new approach rearranges atoms within a DNA strand to repair mutated chemical bases, rather than cutting and replacing the problematic area of the DNA, resulting in a more precise editing tool that could one day treat a range of inherited diseases, some of which currently have no treatment options.
In San Francisco, US District Judge Vince Chhabria upholds President Trump’s executive order stopping cost-sharing subsidy payments to insurers.
The CBO says the bipartisan Alexander-Murray bill, designed to stabilize the ACA individual marketplaces, would reduce the deficit by nearly $4 billion over the next 10 years.